Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activity of nintedanib in germ cell tumors.
Steinemann G, Jacobsen C, Gerwing M, Hauschild J, von Amsberg G, Höpfner M, Nitzsche B, Honecker F. Steinemann G, et al. Among authors: gerwing m. Anticancer Drugs. 2016 Feb;27(2):89-98. doi: 10.1097/CAD.0000000000000305. Anticancer Drugs. 2016. PMID: 26479145
Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells.
Gerwing M, Jacobsen C, Dyshlovoy S, Hauschild J, Rohlfing T, Oing C, Venz S, Oldenburg J, Oechsle K, Bokemeyer C, von Amsberg G, Honecker F. Gerwing M, et al. J Cancer Res Clin Oncol. 2016 Sep;142(9):1979-94. doi: 10.1007/s00432-016-2204-6. Epub 2016 Jul 16. J Cancer Res Clin Oncol. 2016. PMID: 27424191
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse.
Berdel AF, Ruhnke L, Angenendt L, Wermke M, Röllig C, Mikesch JH, Scheller A, Hemmerle T, Matasci M, Wethmar K, Kessler T, Gerwing M, Hescheler D, Schäfers M, Hartmann W, Altvater B, Rossig C, Bornhäuser M, Lenz G, Stelljes M, Rueter B, Neri D, Berdel WE, Schliemann C. Berdel AF, et al. Among authors: gerwing m. Blood Adv. 2022 Jun 28;6(12):3684-3696. doi: 10.1182/bloodadvances.2021006909. Blood Adv. 2022. PMID: 35468621 Free PMC article. Clinical Trial.
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.
Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Stalmann U, Berning B, Kratz-Albers K, Middelberg-Bisping K, Wiebe S, Albring J, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Bormann E, Schmidt H, Lenz G, Kessler T, Mesters RM, Berdel WE. Schliemann C, et al. Among authors: gerwing m. Cancers (Basel). 2020 Jun 7;12(6):1488. doi: 10.3390/cancers12061488. Cancers (Basel). 2020. PMID: 32517329 Free PMC article.
Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access.
Mansour N, Öcal O, Gerwing M, Köhler M, Deniz S, Heinzow H, Steib C, Angele MK, Seidensticker M, Ricke J, Wildgruber M. Mansour N, et al. Among authors: gerwing m. Abdom Radiol (NY). 2022 Mar;47(3):1177-1186. doi: 10.1007/s00261-022-03411-w. Epub 2022 Jan 12. Abdom Radiol (NY). 2022. PMID: 35020007 Free PMC article.
Combined Transarterial Embolization and Percutaneous Sclerotherapy as Treatment for Refractory and Nonresectable Aneurysmal Bone Cysts.
Masthoff M, Gerwing M, Schneider KN, Köhler M, Deventer N, Schindler P, Heindel W, Hardes J, Seidensticker M, Gosheger G, Wildgruber M. Masthoff M, et al. Among authors: gerwing m. J Vasc Interv Radiol. 2021 Oct;32(10):1425-1434.e2. doi: 10.1016/j.jvir.2021.07.008. Epub 2021 Jul 20. J Vasc Interv Radiol. 2021. PMID: 34293437
58 results